ESC 2014.

ODYSSEYCOMBO II: Alirocumab more effective than ezetimibe when statins are insufficient

The aim of the study was to show a reduction in LDL cholesterol with the use of...

SIGNIFY: Ivabradine does not reduce events in patients with stable coronary disease

The increase in heart rate in the setting of chronic coronary artery disease is associated with poor...

ODYSSEY FH I and FH II: Alirocumab in patients with heterozygous familial hypercholesterolemia

The study included patients with a diagnosis of heterozygous familial hypercholesterolemia who were receiving the maximum tolerated...

LISTEN: Rosuvastatin versus atorvastatin in Japanese diabetic patients

The treatment of hyperlipidemia is useful in primary and secondary prevention of chronic heart disease and stroke,...

ESC 2014.

The most relevant presentations from ESC 2014 - Aug.30-Sep.03, Barcelona, Spain. If you cannot view the articles, click...